FDA Import Refusal 799-5296952-4/31/1 — Inventia Healthcare Limited
The FDA refused shipment 799-5296952-4/31/1 from Inventia Healthcare Limited (India) on October 28, 2021. The refused product falls under Drugs and Biologics — RABEPRAZOLE SODIUM (ANTACID) (ANTI-ULCER). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- October 28, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60SCY27 RABEPRAZOLE SODIUM (ANTACID) (ANTI-ULCER)
- Charges
- 75